Delos Santos, Airich T.
HRN: 23-78-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/26/2023
10/05/2023
IV
175mg
Q8hrs
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes